Antimicrobial Agents and Chemotherapy · 1989 · 19 citations · 15 references
MedicineInfectious DiseasesMicrobiologyAntimicrobial PharmacologyAntimicrobial PharmacotherapyMedical MicrobiologyAntibacterial AgentsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistancePharmacokinetics Of AntimicrobialsAntiamebic TherapyEntamoeba-host Interactions
Current therapy of Entamoeba histolytica infection requires use of multiple agents effective at different body sites, including the intestinal lumen, intestinal tissue, and liver. Azithromycin and CP-63,956, new extended-half-life macrolides which reach high levels in tissue, exhibit in vitro antiamebic activity at 18 or 48 h of incubation at concentrations comparable to that of erythromycin and slightly higher than that of metronidazole. Azithromycin and CP-63,956 have the potential to be useful therapeutic agents for all types of E. histolytica infection.
15
James A. Retsema, Agnès Girard, W Schelkly et al. · Antimicrobial Agents and Chemotherapy · 1987 · 461 citations
I. Amebic Dysentery and its Complications
E. B. Adams, I. N. Macleod · Medicine · 1977 · 197 citations